Jump to main content
Jump to site search


Strategies based on metal-based nanoparticles for hypoxic-tumor radiotherapy

Abstract

Radiotherapy (RT) is one of the most effective and frequent clinical cancer treatments. Nevertheless, RT can cause damage to normal tissues around tumor under high-dose ionizing radiation. Sparked by the versatile metal-based nanomaterials, great efforts have been devoted to develop the nanomaterials with high-Z metal elements as radiosensitizers by depositing more energy into tumor for RT enhancement. However, these metal-based nanomaterials-mediated RT are highly O2-dependent. Unfortunately, the O2 concentrations within the majority of solid tumors exhibit low levels, which seriously hampers the antitumor efficacy of these nanomaterials during RT. Therefore, the development of novel metal-based nanomaterials as radiosensitizers capable of avoiding the radioresistance induced by the tumor hypoxia are highly desirable and important. Currently, the most effective approaches to reverse radioresistance of hypoxic tumor are to introduce nanomaterials with the O2-elevated ability by delivering exogenous O2, generating O2 in situ, increasing intratumoral blood flow, or reducing HIF-1 expression to harness O2 level in solid tumors. Besides that, recently, some innovative and simple strategies by employing nanoradiosensitizers with diminished oxygen dependence also have been applied to combat the unmet hypoxic challenges, in which nanoradiosensitizers can target tumor hypoxia for selective RT, enhance oxygen-independent ROS generation, or combine with non-oxygen dependent cancer therapy for synergistic treatments. These approaches and strategies provide new avenues for enhanced hypoxic-tumor RT. Nevertheless, the overall review aimed specifically at these strategies is still rare. Herein, we present an overview about the recent advances of metal-based nanomaterials for hypoxic-tumor RT, and give a detailed discussion about the design and working mechanisms of these strategies in their application of RT. Finally, the current challenges and future perspectives are also pointed out in this field.

Back to tab navigation

Publication details

The article was received on 30 Apr 2019, accepted on 10 Jun 2019 and first published on 11 Jun 2019


Article type: Perspective
DOI: 10.1039/C9SC02107H
Chem. Sci., 2019, Accepted Manuscript
  • Open access: Creative Commons BY-NC license
  •   Request permissions

    Strategies based on metal-based nanoparticles for hypoxic-tumor radiotherapy

    C. Zhang, L. Yan, Z. Gu and Y. zhao, Chem. Sci., 2019, Accepted Manuscript , DOI: 10.1039/C9SC02107H

    This article is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported Licence. Material from this article can be used in other publications provided that the correct acknowledgement is given with the reproduced material and it is not used for commercial purposes.

    Reproduced material should be attributed as follows:

    • For reproduction of material from NJC:
      [Original citation] - Published by The Royal Society of Chemistry (RSC) on behalf of the Centre National de la Recherche Scientifique (CNRS) and the RSC.
    • For reproduction of material from PCCP:
      [Original citation] - Published by the PCCP Owner Societies.
    • For reproduction of material from PPS:
      [Original citation] - Published by The Royal Society of Chemistry (RSC) on behalf of the European Society for Photobiology, the European Photochemistry Association, and RSC.
    • For reproduction of material from all other RSC journals:
      [Original citation] - Published by The Royal Society of Chemistry.

    Information about reproducing material from RSC articles with different licences is available on our Permission Requests page.

Search articles by author

Spotlight

Advertisements